A detailed history of Jpmorgan Chase & CO transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 255 shares of BCLI stock, worth $459. This represents 0.0% of its overall portfolio holdings.

Number of Shares
255
Previous 106 140.57%
Holding current value
$459
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$0.34 - $0.74 $50 - $110
149 Added 140.57%
255 $0
Q1 2024

May 10, 2024

BUY
$0.28 - $0.66 $9 - $23
35 Added 49.3%
106 $0
Q4 2023

Feb 12, 2024

BUY
$0.15 - $0.4 $4 - $12
32 Added 82.05%
71 $0
Q3 2023

Nov 14, 2023

BUY
$0.2 - $2.08 $5 - $60
29 Added 290.0%
39 $0
Q2 2023

Aug 11, 2023

SELL
$2.0 - $3.2 $5,946 - $9,513
-2,973 Reduced 99.66%
10 $0
Q1 2023

May 11, 2023

BUY
$1.43 - $3.3 $4,265 - $9,843
2,983 New
2,983 $9,000
Q2 2022

Aug 11, 2022

SELL
$2.71 - $3.6 $160,247 - $212,875
-59,132 Reduced 24.02%
187,070 $516,000
Q1 2022

May 11, 2022

BUY
$2.92 - $4.19 $154,865 - $222,220
53,036 Added 27.46%
246,202 $827,000
Q4 2021

Feb 10, 2022

SELL
$2.81 - $4.23 $709,614 - $1.07 Million
-252,532 Reduced 56.66%
193,166 $773,000
Q3 2021

Nov 12, 2021

BUY
$3.14 - $4.09 $1.4 Million - $1.82 Million
445,698 New
445,698 $1.47 Million

Others Institutions Holding BCLI

About BRAINSTORM CELL THERAPEUTICS INC.


  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $65.7M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.